A detailed history of Lpl Financial LLC transactions in Pfizer Inc stock. As of the latest transaction made, Lpl Financial LLC holds 8,281,546 shares of PFE stock, worth $232 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
8,281,546
Previous 6,592,773 25.62%
Holding current value
$232 Million
Previous $190 Million 21.08%
% of portfolio
0.13%
Previous 0.12%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$25.89 - $29.73 $43.7 Million - $50.2 Million
1,688,773 Added 25.62%
8,281,546 $230 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $8.46 Million - $11 Million
-323,661 Reduced 4.68%
6,592,773 $190 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $11.2 Million - $13.1 Million
349,581 Added 5.32%
6,916,434 $229 Million
Q2 2023

Jul 31, 2023

BUY
$36.12 - $41.79 $15.8 Million - $18.3 Million
438,067 Added 7.15%
6,566,853 $241 Million
Q1 2023

May 10, 2023

BUY
$39.39 - $51.28 $28.2 Million - $36.6 Million
714,679 Added 13.2%
6,128,786 $250 Million
Q4 2022

Feb 07, 2023

BUY
$41.75 - $54.5 $14.4 Million - $18.8 Million
345,594 Added 6.82%
5,414,107 $278 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $2.05 Million - $2.5 Million
46,763 Added 0.93%
5,068,513 $222 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $2.58 Million - $3.05 Million
55,368 Added 1.11%
5,021,750 $263 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $15.5 Million - $19.2 Million
339,147 Added 7.33%
4,966,382 $257 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $7.96 Million - $11.8 Million
192,717 Added 4.35%
4,627,235 $273 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $5.64 Million - $7.25 Million
143,722 Added 3.35%
4,434,518 $191 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $11.9 Million - $13.5 Million
332,710 Added 8.41%
4,290,796 $168 Million
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $1.96 Million - $2.21 Million
58,487 Added 1.5%
3,958,086 $143 Million
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $14.5 Million - $18.5 Million
434,316 Added 12.53%
3,899,599 $144 Million
Q3 2020

Nov 09, 2020

BUY
$31.75 - $37.25 $9.86 Million - $11.6 Million
310,676 Added 9.85%
3,465,283 $127 Million
Q2 2020

Aug 13, 2020

BUY
$30.12 - $36.54 $9.04 Million - $11 Million
300,070 Added 10.51%
3,154,607 $103 Million
Q1 2020

May 14, 2020

BUY
$27.03 - $38.62 $4.73 Million - $6.76 Million
175,143 Added 6.54%
2,854,537 $93.2 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $14.3 Million - $16.3 Million
435,693 Added 19.42%
2,679,394 $105 Million
Q3 2019

Nov 13, 2019

BUY
$32.49 - $42.13 $8.15 Million - $10.6 Million
250,989 Added 12.6%
2,243,701 $80.6 Million
Q2 2019

Aug 09, 2019

BUY
$36.98 - $41.52 $7.32 Million - $8.22 Million
198,053 Added 11.04%
1,992,712 $86.3 Million
Q1 2019

May 08, 2019

BUY
$37.5 - $41.2 $2.74 Million - $3.01 Million
73,132 Added 4.25%
1,794,659 $76.2 Million
Q4 2018

Feb 07, 2019

SELL
$38.47 - $43.86 $6.83 Million - $7.78 Million
-177,453 Reduced 9.34%
1,721,527 $75.1 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $3.26 Million - $3.96 Million
94,623 Added 5.24%
1,898,980 $83.7 Million
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $388,504 - $414,184
11,780 Added 0.66%
1,804,357 $65.5 Million
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $6.71 Million - $7.79 Million
210,405 Added 13.3%
1,792,577 $63.6 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $5.54 Million - $5.88 Million
166,649 Added 11.77%
1,582,172 $57.3 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $1.24 Million - $1.37 Million
40,005 Added 2.91%
1,415,523 $50.5 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,375,518
1,375,518 $46.2 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.